NO20014293D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20014293D0
NO20014293D0 NO20014293A NO20014293A NO20014293D0 NO 20014293 D0 NO20014293 D0 NO 20014293D0 NO 20014293 A NO20014293 A NO 20014293A NO 20014293 A NO20014293 A NO 20014293A NO 20014293 D0 NO20014293 D0 NO 20014293D0
Authority
NO
Norway
Prior art keywords
polypeptides
new connections
polynucleotides
disclosed
methods
Prior art date
Application number
NO20014293A
Other languages
English (en)
Other versions
NO20014293L (no
Inventor
Claudine Elvire Marie Bruck
Jean-Pol Cassart
Thierry Coche
Carlota Vinals Y De Bassols
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905607.9A external-priority patent/GB9905607D0/en
Priority claimed from GBGB9920590.8A external-priority patent/GB9920590D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20014293D0 publication Critical patent/NO20014293D0/no
Publication of NO20014293L publication Critical patent/NO20014293L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
NO20014293A 1999-03-11 2001-09-04 Nye forbindelser NO20014293L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9905607.9A GB9905607D0 (en) 1999-03-11 1999-03-11 Novel compounds
GBGB9920590.8A GB9920590D0 (en) 1999-09-01 1999-09-01 Novel compounds
PCT/EP2000/002048 WO2000053748A2 (en) 1999-03-11 2000-03-09 Casb618 polynucleotides and polypeptides and their use

Publications (2)

Publication Number Publication Date
NO20014293D0 true NO20014293D0 (no) 2001-09-04
NO20014293L NO20014293L (no) 2001-11-12

Family

ID=26315257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014293A NO20014293L (no) 1999-03-11 2001-09-04 Nye forbindelser

Country Status (22)

Country Link
US (2) US7470782B2 (no)
EP (1) EP1165778B1 (no)
JP (1) JP2002538787A (no)
KR (1) KR100674784B1 (no)
CN (1) CN100430478C (no)
AT (1) ATE342727T1 (no)
AU (1) AU756398B2 (no)
BR (1) BR0008917A (no)
CA (1) CA2366147A1 (no)
CZ (1) CZ20013268A3 (no)
DE (1) DE60031383T2 (no)
DK (1) DK1165778T3 (no)
ES (1) ES2273670T3 (no)
HK (1) HK1044794B (no)
HU (1) HUP0200366A2 (no)
IL (2) IL145047A0 (no)
NO (1) NO20014293L (no)
NZ (1) NZ513838A (no)
PL (1) PL350991A1 (no)
PT (1) PT1165778E (no)
TR (1) TR200102781T2 (no)
WO (1) WO2000053748A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1265915E (pt) * 2000-02-23 2011-02-07 Glaxosmithkline Biolog Sa Novos compostos
US7811574B2 (en) 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
WO2007106509A2 (en) * 2006-03-14 2007-09-20 Genizon Biosciences, Inc. Methods and means for nucleic acid sequencing
US20100021424A1 (en) 2006-06-02 2010-01-28 Vincent Brichard Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy
KR101238795B1 (ko) 2007-05-24 2013-03-07 글락소스미스클라인 바이오로지칼즈 에스.에이. 동결건조 항원 조성물
SG176220A1 (en) 2009-05-27 2011-12-29 Glaxosmithkline Biolog Sa Casb7439 constructs
GB0917457D0 (en) 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688657A (en) * 1988-03-31 1997-11-18 International Bio-Immune Systems, Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5840871A (en) * 1997-01-29 1998-11-24 Incyte Pharmaceuticals, Inc. Prostate-associated kallikrein
GB9806164D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
GB9806095D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
EP1210419A2 (en) * 1999-03-22 2002-06-05 Incyte Pharmaceuticals, Inc. Human transmembrane proteins
US7105315B2 (en) * 1999-06-16 2006-09-12 Incyte Genomics, Inc. Transmembrane protein differentially expressed in cancer
JP2003523726A (ja) * 1999-04-09 2003-08-12 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質

Also Published As

Publication number Publication date
US7470782B2 (en) 2008-12-30
WO2000053748A2 (en) 2000-09-14
DK1165778T3 (da) 2007-02-12
HK1044794A1 (en) 2002-11-01
HUP0200366A2 (en) 2002-06-29
CN1370231A (zh) 2002-09-18
HK1044794B (zh) 2007-05-18
CZ20013268A3 (cs) 2002-02-13
US20060052593A1 (en) 2006-03-09
PT1165778E (pt) 2007-01-31
IL145047A0 (en) 2002-06-30
JP2002538787A (ja) 2002-11-19
CA2366147A1 (en) 2000-09-14
ES2273670T3 (es) 2007-05-16
CN100430478C (zh) 2008-11-05
DE60031383T2 (de) 2007-11-15
WO2000053748A3 (en) 2001-01-11
ATE342727T1 (de) 2006-11-15
KR100674784B1 (ko) 2007-01-25
KR20020008125A (ko) 2002-01-29
US20090202577A1 (en) 2009-08-13
AU3287700A (en) 2000-09-28
TR200102781T2 (tr) 2002-01-21
IL145047A (en) 2008-11-03
NZ513838A (en) 2003-02-28
BR0008917A (pt) 2002-01-15
PL350991A1 (en) 2003-02-24
EP1165778A2 (en) 2002-01-02
AU756398B2 (en) 2003-01-09
DE60031383D1 (de) 2006-11-30
NO20014293L (no) 2001-11-12
EP1165778B1 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
NO20014292L (no) Nye anvendelser
CY1113109T1 (el) Νεες ενωσεις
NO20014293L (no) Nye forbindelser
WO2000058460A3 (en) Casb619 involved in colon cancers
PT1112366E (pt) Polinucleotideos e polipeptideos basb033 da neisseria meningitidis e suas utilizacoes
WO2001023417A3 (en) Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
WO2000043509A3 (en) Polynucleotides and their applications in diagnostics
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
DE69928931D1 (de) Moraxella catarrhalis polynukleotide und polypeptide
WO2001034795A3 (en) Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
DE60019613D1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application